144 related articles for article (PubMed ID: 28992253)
1. In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.
Nagy F; Bozó A; Tóth Z; Daróczi L; Majoros L; Kovács R
Med Mycol; 2018 Jun; 56(4):493-500. PubMed ID: 28992253
[TBL] [Abstract][Full Text] [Related]
2. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Bouza E; Guinea J
J Antimicrob Chemother; 2017 Jul; 72(7):1969-1976. PubMed ID: 28175309
[TBL] [Abstract][Full Text] [Related]
5. Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Kovács R; Bozó A; Gesztelyi R; Domán M; Kardos G; Nagy F; Tóth Z; Majoros L
Int J Antimicrob Agents; 2016 Apr; 47(4):304-10. PubMed ID: 26968084
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
[TBL] [Abstract][Full Text] [Related]
7. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
9. The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
Tóth Z; Bozó A; Kovács R; Balogh B; Balázs B; Forgács L; Kelentey B; Majoros L
Mycopathologia; 2023 Apr; 188(1-2):111-118. PubMed ID: 36399230
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.
Touil HFZ; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
[TBL] [Abstract][Full Text] [Related]
12. Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.
Kovács R; Tóth Z; Nagy F; Daróczi L; Bozó A; Majoros L
J Appl Microbiol; 2017 Jun; 122(6):1529-1536. PubMed ID: 28321957
[TBL] [Abstract][Full Text] [Related]
13. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
14. Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical
Chen YC; Chen FJ; Lee CH
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33252326
[No Abstract] [Full Text] [Related]
15. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
16. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
Mazari W; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2015 Mar; 25(1):57-62. PubMed ID: 25533329
[TBL] [Abstract][Full Text] [Related]
18. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
Shirazi F; Kontoyiannis DP
Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
Med Mycol; 2016 Feb; 54(2):155-61. PubMed ID: 26543157
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of caspofungin against planktonic and sessile Candida sp. cells.
Serefko A; Chudzik B; Malm A
Pol J Microbiol; 2006; 55(2):133-7. PubMed ID: 17419291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]